Key facts
- This page summarizes Richard J. Berman's Form 4 filing for Cryoport, Inc. (CYRX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 21 May 2024, 19:00.
Richard J. Berman - 17 May 2024 Form 4 Insider Report for Cryoport, Inc. (CYRX)
- Reporting relationship
- Director
- Issuer ticker
- CYRX
- Reported as of
- 17 May 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 21 May 2024, 19:00:16 UTC
- Prior SEC filing
- 16 May 2024
- Next SEC filing
- 14 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Richard J. Berman
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Richard J. Berman filed Form 4 for Cryoport, Inc. (CYRX) on 21 May 2024.
Change
- Previous filing in this sequence was filed on 16 May 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CYRX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +12,845
- Change %
- +13%
- Price
- $0.000000
- Shares after
- 112,845
- Date
- 17 May 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CYRX
transaction
Derivative
Option (Right to Buy Common Stock)
Award
- Transaction value
- $0
- Shares
- +23,830
- Change %
- Price
- $0.000000
- Shares after
- 23,830
- Date
- 17 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 23,830
- Exercise price
- $12.65
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Reflects grant of restricted stock rights that vest in full on May 17, 2025, and upon vesting automatically convert to shares of common stock on a one-for-one basis.
Footnote F2
1/12th of the options vest on the 17th of the month for twelve months beginning June 17, 2024.